Literature DB >> 17613356

Liver fibrosis and chronic viral hepatitis.

Gabriela Gutierrez-Reyes1, Maria Concepcion Gutierrez-Ruiz, David Kershenobich.   

Abstract

Liver fibrosis results from chronic damage to the liver in conjunction with the progressive accumulation of fibrillar extracellular matrix proteins. Fibrosis progression in patients with chronic viral hepatitis is a dynamic process where hepatic stellate cells, the most important contributor cell type, respond to a variety of host genetic factors and viral proteins. The abuse of alcohol, superimposed fatty liver disease, and age at the time of viral infection are some of the factors that accelerate liver fibrosis. Liver biopsy remains the gold standard to diagnose fibrosis and significant advances have been made to develop noninvasive markers for liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613356     DOI: 10.1016/j.arcmed.2006.10.001

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  15 in total

1.  Protective effect of sodium ferulate on acetaldehyde-treated precision-cut rat liver slices.

Authors:  Yu Guo; Xiao-Qian Wu; Chun Zhang; Zhang-Xiu Liao; Yong Wu; Hui Wang
Journal:  J Med Food       Date:  2012-03-09       Impact factor: 2.786

2.  Cytoglobin exhibits anti-fibrosis activity on liver in vivo and in vitro.

Authors:  Xin He; Ruoyun Lv; Ke Wang; Xiaofeng Huang; Wutong Wu; Lifang Yin; Yu Liu
Journal:  Protein J       Date:  2011-10       Impact factor: 2.371

3.  The evaluation of fibrotic effects of the hepatitis B virus pre-core in hepatic stellate cells.

Authors:  Seyed Younes Hosseini; Kazem Baesi; Negar Azarpira; Ameneh Pakneiat; Seyedeh Akram Hosseini
Journal:  Biomed Rep       Date:  2017-04-19

Review 4.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

Review 5.  Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.

Authors:  Mark A Feitelson; Helena M G P V Reis; N Lale Tufan; Bill Sun; Jingbo Pan; Zhaorui Lian
Journal:  Cancer Lett       Date:  2009-02-06       Impact factor: 8.679

6.  Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray.

Authors:  Waqar Ahmad; Bushra Ijaz; Sajida Hassan
Journal:  J Transl Med       Date:  2012-03-07       Impact factor: 5.531

Review 7.  A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

Authors:  Waqar Ahmad; Bushra Ijaz; Sana Gull; Sultan Asad; Saba Khaliq; Shah Jahan; Muhammad T Sarwar; Humera Kausar; Aleena Sumrin; Imran Shahid; Sajida Hassan
Journal:  Virol J       Date:  2011-02-08       Impact factor: 4.099

8.  Fucoidan partly prevents CCl4-induced liver fibrosis.

Authors:  Shinji Hayashi; Ayano Itoh; Katsuhiro Isoda; Masuo Kondoh; Masaya Kawase; Kiyohito Yagi
Journal:  Eur J Pharmacol       Date:  2007-11-17       Impact factor: 4.432

9.  Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.

Authors:  Lei Ye; Haisheng Yu; Chengwen Li; Matthew L Hirsch; Liguo Zhang; R Jude Samulski; Wuping Li; Zhong Liu
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 10.  Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.

Authors:  Tung-Hung Su; Jia-Horng Kao; Chun-Jen Liu
Journal:  Int J Mol Sci       Date:  2014-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.